Constipation-predominant Irritable Bowel Syndrome
📧 Sign up to get email alerts when something new happens for Constipation-predominant Irritable Bowel Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-03-21Clinical Trial Update: A Chinese Herbal Medicine for IBS-C [Phase 2]
Phase 2 clinical trial update for a Chinese Herbal Medicine targeting constipation-predominant irritable bowel syndrome.
-
CLINICAL_TRIALS trial_result · 2021-12-13Clinical Trial Update: Efficacy of Linaclotide in Patients With Overlapping Functional Gastrointestinal Disorders [Phase 4]
Phase 4 trial update evaluating the efficacy of linaclotide in patients with overlapping functional GI disorders (functional dyspepsia and c…
-
CLINICAL_TRIALS trial_result · 2020-04-24Clinical Trial Update: A Long-Term Safety Study of Tenapanor for the Treatment of IBS-C [Phase 3]
A long-term safety study (Phase 3) of tenapanor for constipation-predominant irritable bowel syndrome has completed with results posted in 2…
-
CLINICAL_TRIALS trial_result · 2020-04-21Clinical Trial Update: A 12-Week Study With a 4-Week Randomized Withdrawal Period to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of IBS-C [Phase 3]
Phase 3 trial results for tenapanor in constipation-predominant irritable bowel syndrome (IBS-C) with a 12-week treatment and 4-week withdra…
-
CLINICAL_TRIALS trial_result · 2020-04-13Clinical Trial Update: A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C [Phase 3]
Phase 3 trial evaluating tenapanor for constipation-predominant irritable bowel syndrome has completed with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-01-10Clinical Trial Update: The Efficacy of AZD1722 in Constipation Predominant Irritable Bowel Syndrome (IBS-C) [Phase 2, Phase 3]
Phase 2/3 trial update for AZD1722 in constipation-predominant irritable bowel syndrome (IBS-C) completed with posted results.
-
CLINICAL_TRIALS trial_result · 2019-10-15Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of RDX5791 for the Treatment of Constipation Predominant Irritable Bowel Syndrome (IBS-C) [Phase 2]
Phase 2 clinical trial evaluating the safety and efficacy of RDX5791 for constipation-predominant irritable bowel syndrome has completed and…
-
CLINICAL_TRIALS trial_result · 2015-08-10Clinical Trial Update: Neomycin and Rifaximin Plus Neomycin in Treating Methane Positive Constipation Predominant Irritable Bowel Syndrome [NA]
Completed clinical trial evaluating neomycin with rifaximin for methane-positive constipation-predominant irritable bowel syndrome; results …